Page last updated: 2024-08-26

bosentan anhydrous and Joint Pain

bosentan anhydrous has been researched along with Joint Pain in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, Y; Endo, H; Hamaguchi, Y; Ihn, H; Kawaguchi, Y; Kuwana, M; Motegi, SI; Sumida, T; Takehara, K; Tanaka, S	1
Bräuer, R; Gajda, M; Glück, L; Imhof, AK; Schaible, HG; Schulz, S	1
García-Consuegra, J; González-Fernández, MA	1

Trials

1 trial(s) available for bosentan anhydrous and Joint Pain

Article	Year
Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study. The Journal of dermatology, 2017, Volume: 44, Issue:1 Topics: Administration, Oral; Adult; Aged; Anemia; Arthralgia; Bosentan; Constipation; Diarrhea; Endothelin Receptor Antagonists; Female; Fingers; Herpes Zoster; Humans; Japan; Liver; Liver Function Tests; Male; Middle Aged; Prospective Studies; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Wound Healing	2017

Article

Year

Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study.

The Journal of dermatology, 2017, Volume: 44, Issue:1

Topics: Administration, Oral; Adult; Aged; Anemia; Arthralgia; Bosentan; Constipation; Diarrhea; Endothelin Receptor Antagonists; Female; Fingers; Herpes Zoster; Humans; Japan; Liver; Liver Function Tests; Male; Middle Aged; Prospective Studies; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Wound Healing

2017

Other Studies

2 other study(ies) available for bosentan anhydrous and Joint Pain

Article	Year
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis research & therapy, 2011, Jun-20, Volume: 13, Issue:3 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis, Experimental; Bosentan; Disease Models, Animal; Edema; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Nociception; Phenylpropionates; Pyridazines; Secondary Prevention; Sulfonamides	2011
Polyarteritis nodosa resistant to conventional treatment in a pediatric patient. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:5 Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arthralgia; Azathioprine; Bosentan; Child, Preschool; Cyclophosphamide; Female; Fever; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Polyarteritis Nodosa; Sulfonamides; Vasodilator Agents	2007

Article

Year

Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice.

Arthritis research & therapy, 2011, Jun-20, Volume: 13, Issue:3

Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis, Experimental; Bosentan; Disease Models, Animal; Edema; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Nociception; Phenylpropionates; Pyridazines; Secondary Prevention; Sulfonamides

2011

Polyarteritis nodosa resistant to conventional treatment in a pediatric patient.

The Annals of pharmacotherapy, 2007, Volume: 41, Issue:5

Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arthralgia; Azathioprine; Bosentan; Child, Preschool; Cyclophosphamide; Female; Fever; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Polyarteritis Nodosa; Sulfonamides; Vasodilator Agents

2007